Continuous Glucose Monitoring in Type 1 Diabetes Linked to HbA1c Reduction and Modest Weight Changes

A new real-world study in The Lancet Regional Health – Europe indicates that continuous glucose monitoring (CGM) in adults with type 1 diabetes is associated with reduced HbA1c levels. While the study of over 4,000 European users noted a modest average weight gain, it also suggested CGM might protect most users from significant weight increases, highlighting diverse individual responses to the technology.